<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Br J Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Br. J. Dermatol</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)1365-2133</journal-id>
      <journal-id journal-id-type="publisher-id">BJD</journal-id>
      <journal-title-group>
        <journal-title>The British Journal of Dermatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0007-0963</issn>
      <issn pub-type="epub">1365-2133</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25965869</article-id>
      <article-id pub-id-type="pmc">4832349</article-id>
      <article-id pub-id-type="doi">10.1111/bjd.13895</article-id>
      <article-id pub-id-type="publisher-id">BJD13895</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Research Letter</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
          <subj-group subj-group-type="heading">
            <subject>Research Letters</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Novel autosomal dominant mutation in loricrin presenting as prominent ichthyosis</article-title>
      </title-group>
      <contrib-group>
        <contrib id="bjd13895-cr-0001" contrib-type="author">
          <name>
            <surname>Pohler</surname>
            <given-names>E.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0002" contrib-type="author" corresp="yes">
          <name>
            <surname>Cunningham</surname>
            <given-names>F.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0003" contrib-type="author">
          <name>
            <surname>Sandilands</surname>
            <given-names>A.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0004" contrib-type="author">
          <name>
            <surname>Cole</surname>
            <given-names>C.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0005" contrib-type="author">
          <name>
            <surname>Digby</surname>
            <given-names>S.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0004">
<sup>4</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0006" contrib-type="author">
          <name>
            <surname>McMillan</surname>
            <given-names>J.R.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0007" contrib-type="author">
          <name>
            <surname>Aristodemou</surname>
            <given-names>S.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0008" contrib-type="author">
          <name>
            <surname>McGrath</surname>
            <given-names>J.A.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0009" contrib-type="author">
          <name>
            <surname>Smith</surname>
            <given-names>F.J.D.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0010" contrib-type="author">
          <name>
            <surname>McLean</surname>
            <given-names>W.H.I.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0011" contrib-type="author">
          <name>
            <surname>Munro</surname>
            <given-names>C.S.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0007">
<sup>7</sup>
</xref>
        </contrib>
        <contrib id="bjd13895-cr-0012" contrib-type="author">
          <name>
            <surname>Zamiri</surname>
            <given-names>M.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd13895-aff-0002">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="bjd13895-aff-0007">
<sup>7</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="bjd13895-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Centre for Dermatology and Genetic Medicine</named-content>
        <named-content content-type="organisation-division">Colleges of Life Sciences and Medicine, Dentistry and Nursing</named-content>
        <institution>University of Dundee</institution>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd13895-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Department of Dermatology</named-content>
        <institution>University Hospital Crosshouse</institution>
        <named-content content-type="street">Kilmarnock Road</named-content>
        <named-content content-type="city">Kilmarnock</named-content>
        <named-content content-type="post-code">KA2 0BE</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd13895-aff-0003">
        <label>
          <sup>3</sup>
        </label>
        <named-content content-type="organisation-division">Division of Computational Biology</named-content>
        <named-content content-type="organisation-division">College of Life Sciences</named-content>
        <institution>University of Dundee</institution>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd13895-aff-0004">
        <label>
          <sup>4</sup>
        </label>
        <named-content content-type="organisation-division">Department of Pathology</named-content>
        <institution>Southern General Hospital</institution>
        <named-content content-type="city">Glasgow</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd13895-aff-0005">
        <label>
          <sup>5</sup>
        </label>
        <named-content content-type="organisation-division">EB Laboratory</named-content>
        <named-content content-type="organisation-division">Viapath LLP</named-content>
        <named-content content-type="organisation-division">St Thomas' Hospital</named-content>
        <named-content content-type="organisation-division">London Group</named-content>
        <institution>King's College London (Guy's Campus)</institution>
        <named-content content-type="city">London</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd13895-aff-0006">
        <label>
          <sup>6</sup>
        </label>
        <named-content content-type="organisation-division">Department of Cell Pathology</named-content>
        <named-content content-type="organisation-division">St John's Institute of Dermatology</named-content>
        <institution>St. Thomas' Hospital</institution>
        <named-content content-type="city">London</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd13895-aff-0007">
        <label>
          <sup>7</sup>
        </label>
        <named-content content-type="organisation-division">Alan Lyell Centre for Dermatology</named-content>
        <institution>Southern General Hospital</institution>
        <named-content content-type="city">Glasgow</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>
Correspondence: Fiona Cunningham.<break/>
E&#x2010;mail: <email>fionajcunningham@gmail.com</email><break/></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <volume>173</volume>
      <issue>5</issue>
      <issue-id pub-id-type="doi">10.1111/bjd.2015.173.issue-5</issue-id>
      <fpage>1291</fpage>
      <lpage>1294</lpage>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2015 British Association of Dermatologists <copyright-statement>-->
        <copyright-statement content-type="article-copyright">&#xA9; 2015 The Authors. <italic>British Journal of Dermatology</italic> published by John Wiley &amp; Sons Ltd on behalf of British Association of Dermatologists.</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:BJD-173-1291.pdf"/>
      <funding-group>
        <award-group>
          <funding-source>Wellcome Trust Strategic Award</funding-source>
          <award-id>098439/Z/12/Z</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Wellcome Trust Programme</funding-source>
          <award-id>092530/Z/10/Z</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Pachyonychia Congenita Project</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="4"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>bjd13895</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>November 2015</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.6 mode:remove_FC converted:22.04.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <fn-group id="bjd13895-ntgp-0001">
        <fn id="bjd13895-note-0001">
          <p>Funding sources: The Centre for Dermatology and Genetic Medicine at the University of Dundee is supported by a Wellcome Trust Strategic Award (098439/Z/12/Z to W.H.I.M. and J.A.M). This work was also supported by a Wellcome Trust Programme Grant (092530/Z/10/Z to W.H.I.M.) and by a grant from the Pachyonychia Congenita Project (to FJDS, <ext-link ext-link-type="uri" xlink:href="http://www.pachyonychia.org">www.pachyonychia.org</ext-link>).</p>
        </fn>
        <fn id="bjd13895-note-0002">
          <p>Conflicts of interest: None.</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body>
    <p>
<sc>dear editor,</sc> Loricrin keratoderma (syn. Camisa syndrome, OMIM 604117) is a rare autosomal dominant genodermatosis characterized by palmoplantar keratoderma and ichthyosis.<xref rid="bjd13895-bib-0001" ref-type="ref">1</xref>, <xref rid="bjd13895-bib-0002" ref-type="ref">2</xref> It is caused by mutations in loricrin, a small basic protein synthesized in the upper granular layer, which becomes a major constituent of the cornified cell envelope.<xref rid="bjd13895-bib-0003" ref-type="ref">3</xref> Seven distinct mutations in loricrin have been reported in 15 unrelated pedigrees to date.<xref rid="bjd13895-bib-0004" ref-type="ref">4</xref>, <xref rid="bjd13895-bib-0005" ref-type="ref">5</xref>, <xref rid="bjd13895-bib-0006" ref-type="ref">6</xref> We report a multi&#x2010;generation family with prominent ichthyosis and palmoplantar involvement due to a novel mutation in loricrin.</p>
    <p>The proband was a 14&#x2010;year&#x2010;old boy who presented with generalized dryness and scaling affecting his trunk and all four limbs, previously thought to be ichthyosis vulgaris, which was reported from early childhood (Fig.&#xA0;<xref rid="bjd13895-fig-0001" ref-type="fig">1</xref>a). Clinical examination revealed widespread, prominent ichthyosis and mild diffuse transgredient hyperkeratosis of palms and soles. There was no evidence of atopic dermatitis or keratosis pilaris. His mother and eight other family members were similarly affected (Fig.&#xA0;<xref rid="bjd13895-fig-0001" ref-type="fig">1</xref>b). Subsequently, a further child was born with a collodion membrane followed by generalized ichthyosis.</p>
    <fig fig-type="Figure" xml:lang="en" id="bjd13895-fig-0001" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>(a) Pedigree of family with loricrin keratoderma. Filled symbols represent affected individuals. Whole exome sequencing was performed on one affected family member. *marks individuals who were screened for loricrin mutation by Sanger sequencing. (b&#x2013;d) Clinical pictures of (b) the proband: ichthyosis of upper back with brawny appearance and knuckle pads; (c) proband's mother: transgredient hyperkeratosis of palms and soles; (d) proband's grandfather: widespread ichthyosis of forearm and trunk.</p>
      </caption>
      <graphic id="nlm-graphic-1" xlink:href="BJD-173-1291-g001"/>
    </fig>
    <p>Biopsies of affected skin were processed for light and electron microscopy by standard methods (upper back of the proband's mother) or for electron microscopy only (affected acral skin from the proband's grandfather).<xref rid="bjd13895-bib-0007" ref-type="ref">7</xref> Following informed consent, genomic DNA was extracted from blood or saliva samples from 10 affected and unaffected family members (Fig.&#xA0;<xref rid="bjd13895-fig-0001" ref-type="fig">1</xref>a). A whole exome sequencing approach was taken to analyse the proband's DNA (Methods S1; see Supporting Information).</p>
    <p>Light microscopy of skin from the proband's mother showed mild hyperkeratosis, a normal granular layer and no significant parakeratosis (Fig.&#xA0;<xref rid="bjd13895-fig-0002" ref-type="fig">2</xref>a). Electron microscopy of (i) affected acral skin demonstrated mild intracellular oedema, abundant keratohyaline granules in upper layers, with desmosomes and keratin filaments appearing intact and of (ii) affected upper back skin, vacuolar changes and disruption of suprabasal keratinocytes (Fig. <xref rid="bjd13895-fig-0003" ref-type="fig">3</xref>). Whole exome sequencing directed at relevant epidermal genes revealed a novel heterozygous duplication mutation in the loricrin gene in exon 2 (designated c.806dupG), with an insertion of a single base pair resulting in a frameshift leading to a delayed termination codon and elongation of the protein by 22 amino acids (Fig.&#xA0;<xref rid="bjd13895-fig-0002" ref-type="fig">2</xref>d). The mutation was confirmed by Sanger sequencing (Methods S2; see Supporting Information) and was present in affected individuals but was not in unaffected family members (Figs&#xA0;<xref rid="bjd13895-fig-0001" ref-type="fig">1</xref>a, <xref rid="bjd13895-fig-0002" ref-type="fig">2</xref>b,c). This mutation is not on the dbSNP database or NHLBI Exome Variant Server (<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>).</p>
    <fig fig-type="Figure" xml:lang="en" id="bjd13895-fig-0002" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>(a) A biopsy from the proband's mother's skin showing mild hyperkeratosis, a normal granular layer and no significant parakeratosis (original magnification &#xD7; 20). (b&#x2013;d) Mutation analysis. (b) Normal loricrin sequence in exon 2, showing nucleotides 799&#x2013;813 (codons 267&#x2013;271). (c) The equivalent region as in (b) from the proband showing the heterozygous mutation c.806dupG, leading to a delayed termination codon and a mutant protein 22 amino acids longer than wild&#x2010;type. (d) Nucleotide sequence at the 5&#x2032; end of loricrin. The inserted G nucleotide is in bold and indicated with an arrow. The predicted amino acid sequences of the wild&#x2010;type and mutant (underlined) alleles are shown.</p>
      </caption>
      <graphic id="nlm-graphic-3" xlink:href="BJD-173-1291-g002"/>
    </fig>
    <fig fig-type="Figure" xml:lang="en" id="bjd13895-fig-0003" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Semithin sections and ultrastructural images. In semithin sections (a) there was epidermal acanthosis and compact hyperkeratosis with a pattern of diffuse vacuolar change. These vacuoles (small arrows) were predominantly observed in the suprabasal keratinocyte layers. Suprabasal layer keratinocytes also showed focal cytolytic changes and some cells appeared necrotic. (b) Ultrastructurally there was disruption to the normal keratin filament network within suprabasal keratinocytes concurrent with the presence of peri&#x2010;nuclear, membrane&#x2010;bound vacuoles (V), some containing granular material. At higher magnification (c), keratin filament networks (K) were disturbed or showed some clumping particularly around the nucleus (N). Desmosome connections between keratinocytes mostly appeared normal, although there were small detached desmosomes (D) with disrupted keratin filament (K) association in some areas together with a slight widening of intercellular spaces between adjacent keratinocytes and some granular debris (G) present within the intercellular spaces. Scale bars 50 &#x3BC;m (a), 5 &#x3BC;m (b) and 500 nm (c).</p>
      </caption>
      <graphic id="nlm-graphic-5" xlink:href="BJD-173-1291-g003"/>
    </fig>
    <p>Six different heterozygous insertion mutations in loricrin in 14 unrelated pedigrees have previously been reported&#xA0;and one heterozygous deletion in a further pedigree<xref rid="bjd13895-bib-0002" ref-type="ref">2</xref>, <xref rid="bjd13895-bib-0004" ref-type="ref">4</xref>, <xref rid="bjd13895-bib-0005" ref-type="ref">5</xref>, <xref rid="bjd13895-bib-0006" ref-type="ref">6</xref>, <xref rid="bjd13895-bib-0008" ref-type="ref">8</xref>, <xref rid="bjd13895-bib-0009" ref-type="ref">9</xref>, <xref rid="bjd13895-bib-0011" ref-type="ref">11</xref>, <xref rid="bjd13895-bib-0012" ref-type="ref">12</xref>, <xref rid="bjd13895-bib-0013" ref-type="ref">13</xref> (see Supporting Information; Table&#xA0;S1). All six insertion mutations are single base&#x2010;pair insertions leading to delayed termination codons with the most frequent mutation 730insG being present in eight of the 14 published families.<xref rid="bjd13895-bib-0002" ref-type="ref">2</xref>, <xref rid="bjd13895-bib-0004" ref-type="ref">4</xref>, <xref rid="bjd13895-bib-0008" ref-type="ref">8</xref>, <xref rid="bjd13895-bib-0009" ref-type="ref">9</xref>, <xref rid="bjd13895-bib-0011" ref-type="ref">11</xref>, <xref rid="bjd13895-bib-0012" ref-type="ref">12</xref>, <xref rid="bjd13895-bib-0013" ref-type="ref">13</xref> This region of the loricrin gene is thought to be a mutation hotspot because of the presence of six consecutive guanine nucleotides.<xref rid="bjd13895-bib-0012" ref-type="ref">12</xref>All single&#x2010;base&#x2010;pair insertion and deletion mutations lead to a frameshift and delayed termination, thus elongating the protein by 22 amino acids and changing the Gly&#x2010;Lys&#x2010;rich domain into an Arg&#x2010;Leu&#x2010;rich terminal domain,<xref rid="bjd13895-bib-0002" ref-type="ref">2</xref> except for two pedigrees of Brazilian origin, where the new protein is 25 amino acids longer than wild&#x2010;type protein.<xref rid="bjd13895-bib-0005" ref-type="ref">5</xref> The mechanism of action of these mutations is thought to relate to preferential localization of mutant loricrin in the nucleus due to the formation of nuclear localization sequences within the arginine&#x2010;rich mutant loricrin.<xref rid="bjd13895-bib-0014" ref-type="ref">14</xref> It has been suggested that the abnormal nuclear protein may disrupt the apoptotic process in terminal differentiation of keratinocytes in mouse models, thus supporting the hypothesis that the phenotype of loricrin keratoderma is caused by the synthesis of mutant loricrin rather than by the lack of wild&#x2010;type loricrin.<xref rid="bjd13895-bib-0014" ref-type="ref">14</xref>, <xref rid="bjd13895-bib-0015" ref-type="ref">15</xref> No clear genotype&#x2010;phenotype associations for pedigrees with specific mutations have currently been identified.<xref rid="bjd13895-bib-0004" ref-type="ref">4</xref>, <xref rid="bjd13895-bib-0005" ref-type="ref">5</xref>, <xref rid="bjd13895-bib-0013" ref-type="ref">13</xref>
</p>
    <p>The phenotype of loricrin keratoderma is heterogeneous. The common clinical features in both the 15 previously reported pedigrees and our new pedigree are palmoplantar keratoderma, usually of a honeycomb pattern, and generalized ichthyosis. Other features, including knuckle pads, pseudoainhum/hyperconstricting bands with autoamputation of digits and collodion babies, are variably reported. Previously, Gedicke <italic>et&#xA0;al</italic>.<xref rid="bjd13895-bib-0013" ref-type="ref">13</xref> have suggested that the term &#x2018;mutilating keratoderma with ichthyosis&#x2019; is not entirely suitable, due to the variation in phenotypes previously reported. Similarly, given the prominence of generalized ichthyosis with lesser palmoplantar involvement in this pedigree, and the presence of generalized ichthyosis in all previously reported pedigrees, we suggest that the condition could be described as loricrin ichthyosis rather than loricrin keratoderma.</p>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Methods S1.</bold> Whole exome sequencing.</p>
        </caption>
        <media xlink:href="BJD-173-1291-s001.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Methods S2.</bold> Confirmation of mutation in exon 2 by Sanger sequencing</p>
        </caption>
        <media xlink:href="BJD-173-1291-s002.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Table&#xA0;S1.</bold> Clinical features of families with loricrin keratoderma.</p>
        </caption>
        <media xlink:href="BJD-173-1291-s003.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="bjd13895-sec-0002">
      <title>Acknowledgments</title>
      <p>We would like to thank the patients, their family members and control subjects for their cooperation in this study.</p>
    </ack>
    <ref-list content-type="cited-references" id="bjd13895-bibl-0001">
      <title>References</title>
      <ref id="bjd13895-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0001">
<string-name>
<surname>Camisa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rosanna</surname>
<given-names>C</given-names>
</string-name>. <article-title>Variant of keratoderma hereditaria mutilans (Vohwinkel's syndrome). Treatment with orally administered isotretinoin</article-title>. <source>Arch Dermatol</source>
<year>1984</year>; <volume>120</volume>:<fpage>1323</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">6237617</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0002">
<string-name>
<surname>Maestrini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Monaco</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>McGrath</surname>
<given-names>JA</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome</article-title>. <source>Nat Genet</source>
<year>1996</year>; <volume>13</volume>:<fpage>70</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">8673107</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0003">
<string-name>
<surname>Ishida&#x2010;Yamamoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kiyama</surname>
<given-names>H</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>Mutant loricrin is not crosslinked into the cornified cell envelope but is translocated into the nucleus in loricrin keratoderma</article-title>. <source>J Invest Dermatol.</source>
<year>2000</year>; <volume>115</volume>:<fpage>1088</fpage>&#x2013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">11121146</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0004">
<string-name>
<surname>Yeh</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Chao</surname>
<given-names>SC</given-names>
</string-name>. <article-title>Collodion baby and loricrin keratoderma: a case report and mutation analysis</article-title>. <source>Clin Exp Dermatol</source>
<year>2013</year>; <volume>38</volume>:<fpage>147</fpage>&#x2013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">22831754</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0005">
<string-name>
<surname>Hotz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bourrat</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hausser</surname>
<given-names>I</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>Two novel mutations in the LOR gene in three families with loricrin keratoderma</article-title>. <source>Br J Dermatol</source>
<year>2014</year>; <volume>172</volume>:<fpage>1158</fpage>&#x2013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">25234742</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0006">
<string-name>
<surname>Kinsler</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Drury</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>A</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>Novel microdeletion in LOR causing autosomal dominant loricrin keratoderma</article-title>. <source>Br J Dermatol</source>
<year>2015</year>; <volume>172</volume>:<fpage>262</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">25142840</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="book" id="bjd13895-cit-0007">
<string-name>
<surname>Hayat</surname>
<given-names>MA</given-names>
</string-name>. <chapter-title>Rinsing, dehydrating and embedding</chapter-title> In: <source>Principles and&#xA0;Techniques of Electron Microscopy: Biological Applications</source>, <edition>3rd edn</edition>
<publisher-loc>Basingstoke</publisher-loc>: <publisher-name>Macmillan Press</publisher-name>, <year>1989</year>; <fpage>79</fpage>&#x2013;<lpage>137</lpage>.</mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0008">
<string-name>
<surname>Korge</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Ishida&#x2010;Yamamoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Punter</surname>
<given-names>C</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis</article-title>. <source>J Invest Dermatol</source>
<year>1997</year>; <volume>109</volume>:<fpage>604</fpage>&#x2013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">9326398</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0009">
<string-name>
<surname>O'Driscoll</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Muston</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>McGrath</surname>
<given-names>JA</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>A recurrent mutation in the loricrin gene underlies the ichthyotic variant of Vohwinkel syndrome</article-title>. <source>Clin Exp Dermatol</source>
<year>2002</year>; <volume>27</volume>:<fpage>243</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">12072018</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0010">
<string-name>
<surname>Matsumoto</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Muto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sekin</surname>
<given-names>S</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>Loricrin keratoderma: a cause of congenital ichthyosiform erythroderma and collodion baby</article-title>. <source>Br J&#xA0;Dermatol</source>
<year>2001</year>; <volume>145</volume>:<fpage>657</fpage>&#x2013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">11703298</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0011">
<string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ishida&#x2010;Yamamoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kishi</surname>
<given-names>A</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>Loricrin gene mutation in a Japanese patient of Vohwinkel syndrome</article-title>. <source>J Dermatol Sci</source>
<year>1999</year>; <volume>19</volume>:<fpage>44</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">9890374</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0012">
<string-name>
<surname>Drera</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tadini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Balbo</surname>
<given-names>G</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>
<italic>De novo</italic> occurrence of the 730insG recurrent mutation in an Italian family with the ichthyotic variant of Vohwinkel syndrome, loricrin keratoderma</article-title>. <source>Clin Genet</source>
<year>2008</year>; <volume>73</volume>:<fpage>85</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">17953701</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0013">
<string-name>
<surname>Gedicke</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Traupe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>B</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>Towards characterization of palmoplantar keratoderma caused by gain&#x2010;of&#x2010;function mutation in loricrin: analysis of a family and review of the literature</article-title>. <source>Br J Dermatol</source>
<year>2006</year>; <volume>154</volume>:<fpage>167</fpage>&#x2013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">16403113</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0014">
<string-name>
<surname>Ishida&#x2010;Yamamoto</surname>
<given-names>A</given-names>
</string-name>. <article-title>Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin</article-title>. <source>J Dermatol Sci</source>
<year>2003</year>; <volume>31</volume>:<fpage>3</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">12615358</pub-id></mixed-citation>
      </ref>
      <ref id="bjd13895-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="bjd13895-cit-0015">
<string-name>
<surname>Suga</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jarnik</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Attar</surname>
<given-names>PS</given-names>
</string-name>
<italic>et&#xA0;al</italic>
<article-title>Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma</article-title>. <source>J Cell Biol</source>
<year>2000</year>; <volume>151</volume>:<fpage>401</fpage>&#x2013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">11038186</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
